[HTML][HTML] Dissemination of Registered COVID-19 Clinical Trials (DIRECCT): a cross-sectional study
M Salholz-Hillel, M Pugh-Jones, N Hildebrand… - BMC medicine, 2023 - Springer
Background The results of clinical trials should be completely and rapidly reported during
public health emergencies such as COVID-19. This study aimed to examine when, and …
public health emergencies such as COVID-19. This study aimed to examine when, and …
Results availability and timeliness of registered COVID-19 clinical trials: interim cross-sectional results from the DIRECCT study
M Salholz-Hillel, P Grabitz, M Pugh-Jones, D Strech… - BMJ open, 2021 - bmjopen.bmj.com
Objective To examine how and when the results of COVID-19 clinical trials are
disseminated. Design Cross-sectional study. Setting The COVID-19 clinical trial landscape …
disseminated. Design Cross-sectional study. Setting The COVID-19 clinical trial landscape …
A large number of COVID-19 interventional clinical trials were registered soon after the pandemic onset: a descriptive analysis
AA Nasrallah, SH Farran, ZA Nasrallah… - Journal of clinical …, 2020 - Elsevier
Abstract Background and Objective There is a pressing need for evidence-based
interventions to address the devastating clinical and public health effects of the coronavirus …
interventions to address the devastating clinical and public health effects of the coronavirus …
[HTML][HTML] Analysis of clinical and methodological characteristics of early COVID-19 treatment clinical trials: so much work, so many lost opportunities
Background The COVID-19 pandemic continues to rage on, and clinical research has been
promoted worldwide. We aimed to assess the clinical and methodological characteristics of …
promoted worldwide. We aimed to assess the clinical and methodological characteristics of …
[HTML][HTML] The worldwide clinical trial research response to the COVID-19 pandemic-the first 100 days
Background: Never before have clinical trials drawn as much public attention as those
testing interventions for COVID-19. We aimed to describe the worldwide COVID-19 clinical …
testing interventions for COVID-19. We aimed to describe the worldwide COVID-19 clinical …
[PDF][PDF] COVID-evidence: a living database of trials on interventions for COVID-19
Background: The COVID-19 pandemic is characterized by an unprecedented urgency to
obtain reliable information on therapeutic options and their evaluation in clinical trials …
obtain reliable information on therapeutic options and their evaluation in clinical trials …
COVID-19 clinical trials registered worldwide for drug intervention: an overview and characteristic analysis
B Wang, J Lai, X Yan, F Jin, B Yi, C An… - Drug Design …, 2020 - Taylor & Francis
Objective This study aims to comprehensively evaluate the characteristics of clinical drug
trials to facilitate the collection of evidence for COVID-19 drug treatments. Methods A …
trials to facilitate the collection of evidence for COVID-19 drug treatments. Methods A …
Characteristics of COVID-19 clinical trials registered with ClinicalTrials. gov: cross-sectional analysis
CW Jones, AL Woodford, TF Platts-Mills - BMJ open, 2020 - bmjopen.bmj.com
Objectives To characterise current COVID-19-related research activities. Design Cross-
sectional analysis. Setting Clinical trials registered with ClinicalTrials. gov testing …
sectional analysis. Setting Clinical trials registered with ClinicalTrials. gov testing …
[HTML][HTML] Appealing for efficient, well organized clinical trials on COVID-19
Background The rapid emergence of clinical trials on COVID-19 stimulated a wave of
discussion in scientific community. It is important to understand the characteristics of the …
discussion in scientific community. It is important to understand the characteristics of the …
[HTML][HTML] An evidence mapping and analysis of registered COVID-19 clinical trials in China
L Lu, F Li, H Wen, S Ge, J Zeng, W Luo, L Wang… - BMC medicine, 2020 - Springer
Background This article aims to summarize the key characteristics of registered trials of 2019
novel coronavirus (COVID-19), in terms of their spatial and temporal distributions, types of …
novel coronavirus (COVID-19), in terms of their spatial and temporal distributions, types of …